期刊文献+

双波长HPLC法研究地奥司明在体内的药代动力学 被引量:2

下载PDF
导出
摘要 目的以HPLC双波长扫描法研究地奥司明片的人体药代动力学。方法 20名健康男性受试者,分别单剂量口服地奥司明片1 g。采用HPLC紫外双波长扫描法测定血浆中地奥司明代谢物地奥亭浓度。结果地奥亭的主要药动学参数分别为:AUC0-t(0.821±0.1032)(μg.h)/L;AUC0-∞(1.243 6±0.162 4)(μg.h)/L;Cmax(0.121 6±0.013 2)μg/L,MRT0-t(3.68±0.75)h,MRT0-∞(3.82±0.71)h,Tmax(1.1±0.4)h,T1/2(22.4±7.1)h。结论 HPLC双波长扫描法适用于地奥司明片体内药代动力学的研究。
作者 陈敏 郑仁礼
出处 《现代中西医结合杂志》 CAS 2012年第6期636-638,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献6

  • 1Dieterling P.Contribution of anorectal manometry to the treatment of hemorrhoids[J].Phlebologie,1992,21(Suppl 2):57-60.
  • 2Buckshee K,Takkar D,Aggarwal N.Micronized flavonoid therapy in internal hemorrhoids of pregnancy[J].Int J Gynaecol Obstet,1997,57(2):145-151.
  • 3Dianae G,Catanzaro M,Ferrara A,et al.Actitity diosnin in the Treatment of Homerrhoids[J].Clin Ter,2000,151(5):341.
  • 4Meshikhes AW.Daflon for haerrhoids:apropective,multi centre observational study[J].Surgeon,2004,2(6):335.
  • 5Cesaone MR,Belcero G,Rohdewld P,et al.Comparison of pycnogenol and daflon in treating chronic venous insufficiency:aprospective,controlled study[J].Clin Appl Thrornb Hemost,2006,12(2):205.
  • 6李树民,于定荣,张琳.地奥司明片的生物等效性[J].中国临床药学杂志,2007,16(6):344-347. 被引量:4

二级参考文献5

  • 1Diana G,Catanzare M,Ferrara A,et al.Activity diosmin in the treatment of hemorrhoids[J].Clin Ter,2000,151(5):341.
  • 2Meshikhes AW.Daflon for haemorrhids:a prospecive,multi-centre observational study[J].Surgeon,2004,2(6):335.
  • 3Cesarone MR,Belcaro G,Rohdewald P,et al.Comparison of pycnogenol and daflon in treating chronic venous insufficiency:a prospective,controlled study[J].Clin Appl Thromb Hemost,2006,12(2):205.
  • 4Cova D,De Angelis L,Giavarini F,et al.Pharmacokineics and metabolism of oral diosmin in healthy volunteers[J].Int J Clin Pharmacol Ther Toxicol,1992,30(1):29.
  • 5Kanaze FI,Bounartzi MI,Niopas I.A validated HPLC determination of the flavone aglycone dioemetin in human plasma[J].Biomed Chromatogr,2004,18(10):800.

共引文献3

同被引文献19

  • 1文爱东,吴寅,杨春娥,杨志福,王莉,王志睿,周伦.地奥司明片在健康人体内的药物动力学[J].中国药师,2007,10(7):632-634. 被引量:15
  • 2Diosmin (monograph)[J].Altern Med Rev, 2004, 9(3):308-311.
  • 3LYSENG-WILLIAMSON KA, PERRY CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids[J]. Drugs, 2003, 63(1):71-100.
  • 4KANAZE FI, BOUNARTZI MI, NIOPAS I. A validated HPLC determination of the flavone aglycone diosmetin in human plasma[J]. Biomed Chromatogr, 2004, 18(10): 800-804.
  • 5SPANAKIS M, KASMAS S, NIIOPAS I. Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic reduction of diosmetin to hesperetin[J]. Biomed Chromatogr, 2009, 23(2): 124-131.
  • 6CAMPANERO MA, ESCOLAR M, PEREZ G, et al. Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study[J]. J Pharm Biomed Anal, 2010, 51(4): 875-881.
  • 7国家药典委员会. 药物制剂人体生物利用度和生物等效性研究技术指导原则[S]//中华人民共和国药典: 二部. 北京: 中国医药科技出版社, 2010: 附录XIX B 195.
  • 8SILVESTRO L, TARCOMNICU I, DULEA C, et al. Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry[J]. Anal Bioanal Chem, 2013, 405(25): 8295-8310.
  • 9BLAUT M, SCHOEFER L, BRAUNE A. Transformation of flavonoids by intestinal microorganisms[J]. Int J Vitam and Nutr Res, 2003, 73(2): 79-87.
  • 10李树民,于定荣,张琳.地奥司明片的生物等效性[J].中国临床药学杂志,2007,16(6):344-347. 被引量:4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部